Article info

Download PDFPDF

Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020
Free

Authors

  1. Correspondence to Stephanie Lheureux, Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada; Stephanie.Lheureux{at}uhn.ca

Citation

Madariaga A, Bonilla L, McMullen M, et al
Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020

Publication history

  • Received June 11, 2020
  • Accepted June 15, 2020
  • First published July 9, 2020.
Online issue publication 
August 03, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.